ResearcherCedars-Sinai Medical CenterNo recent work listed
Liron Limor Israel
Matched on ORCID iD 0000-0003-4411-5857; OpenAlex author ID A5078820584. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2015: 1 paper · 2016: 2 papers · 2017: 1 paper · 2018: 1 paper
Papers 5
- A Nanomedicine Approach to Manage Cancer - Imaging Pancreatic Cancer Using Targeted Iron Oxide Nanoparticles. Co-author DOI 10.1016/j.ebiom.2018.03.011↗
- Corrigendum to "Matrix metalloproteinase-9 (MMP-9) as an activator of nanosystems for targeted drug delivery in pancreatic cancer" [J. Control. Release 239 (20… Co-author DOI 10.1016/j.jconrel.2017.07.027↗
- Matrix metalloproteinase-9 (MMP-9) as an activator of nanosystems for targeted drug delivery in pancreatic cancer. Co-author DOI 10.1016/j.jconrel.2016.08.016↗
- Synthesis and functionalization of protease-activated nanoparticles with tissue plasminogen activator peptides as targeting moiety and diagnostic tool for panc… Co-author DOI 10.1186/s12951-016-0236-3↗
- Targeted diagnostic magnetic nanoparticles for medical imaging of pancreatic cancer. Co-author DOI 10.1016/j.jconrel.2015.07.017↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Mauro Comes Franchini · 3 shared papers, 2016–2017 · strength 0.17
- Paper Corrigendum to "Matrix metalloproteinase-9 (MMP-9) as an activator of nanosystems for targeted drug delivery in pancrea… DOI 10.1016/j.jconrel.2017.07.027↗
- Paper Matrix metalloproteinase-9 (MMP-9) as an activator of nanosystems for targeted drug delivery in pancreatic cancer. DOI 10.1016/j.jconrel.2016.08.016↗
- Paper Synthesis and functionalization of protease-activated nanoparticles with tissue plasminogen activator peptides as targe… DOI 10.1186/s12951-016-0236-3↗
- Ghislain Opdenakker · 3 shared papers, 2016–2017 · strength 0.17
- Paper Corrigendum to "Matrix metalloproteinase-9 (MMP-9) as an activator of nanosystems for targeted drug delivery in pancrea… DOI 10.1016/j.jconrel.2017.07.027↗
- Paper Matrix metalloproteinase-9 (MMP-9) as an activator of nanosystems for targeted drug delivery in pancreatic cancer. DOI 10.1016/j.jconrel.2016.08.016↗
- Paper Synthesis and functionalization of protease-activated nanoparticles with tissue plasminogen activator peptides as targe… DOI 10.1186/s12951-016-0236-3↗
- Achim Krüger · 2 shared papers, 2016–2017 · strength 0.12
- Paper Corrigendum to "Matrix metalloproteinase-9 (MMP-9) as an activator of nanosystems for targeted drug delivery in pancrea… DOI 10.1016/j.jconrel.2017.07.027↗
- Paper Matrix metalloproteinase-9 (MMP-9) as an activator of nanosystems for targeted drug delivery in pancreatic cancer. DOI 10.1016/j.jconrel.2016.08.016↗
- Barbara T. Grünwald · 2 shared papers, 2016–2017 · strength 0.12
- Paper Corrigendum to "Matrix metalloproteinase-9 (MMP-9) as an activator of nanosystems for targeted drug delivery in pancrea… DOI 10.1016/j.jconrel.2017.07.027↗
- Paper Matrix metalloproteinase-9 (MMP-9) as an activator of nanosystems for targeted drug delivery in pancreatic cancer. DOI 10.1016/j.jconrel.2016.08.016↗
- Sophie Dobiasch · 2 shared papers, 2015–2016 · strength 0.09
- Klaus Felix · 2 shared papers, 2015–2016 · strength 0.09
- Lars Grenacher · 2 shared papers, 2015–2016 · strength 0.09
- Jens Werner · 2 shared papers, 2015–2016 · strength 0.09
- Ina Rosenberger · 1 shared paper, 2015 · strength 0.04
- María Jiménez-González · 1 shared paper, 2015 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.